Remosense POC Milestone

Remosense POC Milestone

Share on facebook
Share on twitter
Share on linkedin

The Telebionix engineering team successfully completed the Remosense proof of concept achieving their one-hundred-day milestone.

“It would not have been possible without the planning and dedication of the team.”

Widy Medina, CEO of Telebionix

The team is one step closer to the productization of this biometric signal reading device. The Remosense is compact, accurate, precise, and will be the first of its kind in the market. It showcases an Ai driven Digital stethoscope able to red flag abnormal conditions based on spectrograph analysis of audio information.

As this phase comes to a close Medina commented “we are excited to begin the next investment cycle as we should convert our efforts into positive ROI by end of 2021”.